Search clinical trials for: Sodium-Glucose Transporter 2 Inhibitors
Total 16057 results
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
The Catholic University of KoreaAstraZeneca; Severance Hospital; Eulji General Hospital; Kyung Hee University Hospital...Completed
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes | High Blood SugarJapan
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Bulgaria, Russian Federation, United Kingdom, Hungary, Romania, Finland, Canada, Austria, Germany, Netherlands, Slovakia, Spain
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusJapan
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedHepatic Insufficiency | HealthyUnited States
-
AstraZenecaBristol-Myers SquibbSuspended
-
Assiut UniversityCompleted
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, France, Israel, Mexico, South Africa
-
Samsung Medical CenterNot yet recruitingHeart Failure, Preserved Ejection FractionKorea, Republic of
-
Singapore General HospitalDuke-NUS Graduate Medical SchoolTerminatedDiabetic NephropathiesSingapore
-
Brigham and Women's HospitalNovo Nordisk A/S via Research Grant to Brigham and Women's HospitalCompletedCardiovascular Diseases | DiabetesUnited States
-
University of PatrasActive, not recruitingDiabetes Mellitus, Type 2Greece
-
Eli Lilly and CompanyRecruitingType 2 DiabetesTaiwan, United States, China, Mexico, Germany, Poland
-
AstraZenecaRecruitingChronic Kidney Disease With High ProteinuriaItaly, United States, Poland, Germany, Argentina, Denmark, Norway, Spain, Sweden, Bulgaria, France, China, Taiwan, Thailand, Vietnam, Brazil, Japan, Malaysia, Mexico, Philippines, Israel, United Kingdom, South Africa, Austria, Korea, Republic... and more
-
Ottawa Heart Institute Research CorporationNot yet recruitingCoronary Artery Disease | Diabetes Type 2Canada
-
Frank RuschitzkaAstraZenecaRecruiting
-
Columbia UniversityWithdrawnHeart Failure | Sleep Disordered BreathingUnited States
-
Boehringer IngelheimEli Lilly and Company; Medical Research Council Population Health Research...Active, not recruitingChronic Kidney DiseaseUnited States, Canada, United Kingdom, China, Germany, Italy, Japan, Malaysia
-
Asan Medical CenterMerck Sharp & Dohme LLCCompletedMitral Valve Insufficiency | Left Ventricular Systolic DysfunctionKorea, Republic of
-
Emory UniversityCompletedHeart Failure | DiabetesUnited States
-
George Washington UniversityJanssen Scientific Affairs, LLCCompletedType 2 Diabetes MellitusUnited States
-
Yonsei UniversityUnknownHeart Failure With Nonischemic CardiomyopathyKorea, Republic of
-
Daewoong Pharmaceutical Co. LTD.Completed
-
Medanta, The Medicity, IndiaCompletedNon Alcoholic Fatty Liver DiseaseIndia
-
University of PadovaAzienda Ospedaliera di PadovaCompleted
-
Oslo University HospitalCompletedDiabetes Mellitus | Renal Insufficiency | Safety IssuesNorway
-
Osaka UniversityUnknownDiabetes Mellitus, Type 2Japan
-
University of DundeeEuropean Foundation for the Study of DiabetesCompletedHeart Failure | DiabetesUnited Kingdom
-
University of Erlangen-Nürnberg Medical SchoolCompletedDiabetes Mellitus Type 2Germany
-
Boehringer IngelheimCompleted
-
AstraZenecaBristol-Myers SquibbTerminated
-
Merck Sharp & Dohme LLCPfizerCompletedType 2 Diabetes Mellitus (T2DM)
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusUnited States
-
Boehringer IngelheimCompleted
-
Astellas Pharma IncCompletedHealthy | Plasma Concentration of ASP1941Japan
-
Taipei Medical University WanFang HospitalUnknown
-
GlaxoSmithKlineCompletedA Study To Compare Effects Of GSK189075 In Combination With Either Furosemide Or HydrochlorothiazideDiabetes Mellitus, Type 2 | Type 2 Diabetes MellitusUnited States
-
Boehringer IngelheimRecruitingKidney Disease, ChronicKorea, Republic of
-
The George InstituteMonash University; University of Sydney; The University of New South WalesRecruitingType 2 DiabetesAustralia
-
Icahn School of Medicine at Mount SinaiRecruitingHeart Failure With Reduced Ejection Fraction | CongestionUnited States
-
University of California, San FranciscoRecruiting
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
AgelessRxEnrolling by invitation
-
The University of Texas Health Science Center at...AstraZenecaCompletedDiabetes Mellitus, Type 2United States
-
University Health Network, TorontoMerck Sharp & Dohme LLC; University Medical Center Groningen; University of Toronto and other collaboratorsCompletedHeart Failure | Type 2 Diabetes MellitusNetherlands, Canada
-
Mansoura UniversityActive, not recruitingLupus Nephritis | SLE | SGLT2 InhibitorsEgypt
-
RWTH Aachen UniversityBoehringer IngelheimTerminated
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Croatia, Italy, Poland, Russian Federation, Spain, Greece, Serbia, Thailand, Brazil, Hungary, Argentina